A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen
NCT ID: NCT00341588
Last Updated: 2020-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2772 participants
OBSERVATIONAL
2002-01-18
2020-08-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The DoDSR serum sample will be tested for organochlorines levels, gonadotropin levels, and viral antibody titres. Each participant will donate a saliva specimen that will be used in an examination of genetic susceptibility. Each participant will also complete a questionnaire concerning a variety of possible risk factors such as physical activity, medical history, medication history, and other risk factors. The mothers of all participants will be invited to participate by completing a questionnaire concerning perinatal exposures and events and by donating a saliva sample.
The three main objectives of this study are to:
* determine whether environmental endocrine modulators (i.e., chlorinated pesticides and polychlorinated biphenyls) are related to risk of GCT and, if so, whether their effects are augmented by other risk factors.
* determine whether genetic susceptibility to GCT exists and to characterize the environmental risk factors related to that susceptibility.
* determine whether there are distinct causes of GCT by relating the tissue structures of the tumors to the risk factors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk
NCT00820287
Cause of Familial Testicular Cancer
NCT00034424
Diagnostic Study of Patients With Stage I Testicular Cancer
NCT00003800
Germ Cell Tumor and Testicular Tumor DNA Registry
NCT02099734
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
NCT02303015
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 1682 servicemen were enrolled in the study; 754 cases and 928 controls. Of these participants, 1303 men (77%, 590 cases, 713 controls) donated buccal cell samples. In addition to the servicemen, a total of 1090 mothers of servicemen were enrolled and 952 (87%) provided a buccal specimen. The DoDSR serum samples have been assayed for levels of organochlorines pesticides, polychlorinated biphenyl congeners, insulin-like growth factors and gonadotropins and steroid hormones. DNA isolated from the buccal cell specimens have thus far been genotyped for polymorphysms in the hormone metabolism and immune function pathway, immune function pathway, insulin-like growth factor pathway and for single nucleotide polymorphisms in the 8q24 locus. In addition, a genome-wide association study has completed. Statistical analyses of the questionnaire data are continuing.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases
Male U.S. serviceman, age 18-45 years old with TGCT
No interventions assigned to this group
Controls
Male U.S. serviceman, age 18-45 years old without TGCT
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Matched controls will be identified through the DMSS.
Criteria for Cases include:
Age between 17 and 45 years at time of confirmed TGCT diagnosis.
Age of at least 18 years at time of study enrollment.
The existence of a pre-diagnostic serum sample of 1mL or greater in the DoDSR.
On active duty at time of diagnosis.
Donated a serum sample to the DoDSR between the years 1989 and 2003.
Criteria for Control Identification:
Case subjects will be matched with case men on age, ethnicity, and date of serum donation to men in the DoDSR who have never had a diagnosis of TGCT (control men).
Criteria for Control Men include:
No previous diagnosis of TGCT.
Donated a serum sample to the DpDSR between the years 1989 and 2003.
Alive at study initiation.
On active duty at time of case's diagnosis.
18 Years
120 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katherine A McGlynn, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02-C-N113
Identifier Type: -
Identifier Source: secondary_id
999902113
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.